Experimental drug inhibits or prevents diabetic eye disease: In mice and human cell models, the drug 32-134D lowered protein levels known to contribute to diabetic macular edema and diabetic retinopathy

Researchers say they have evidence that an experimental drug may prevent or slow vision loss in people with diabetes. The results are from a study that used mouse as well as human retinal organoids and eye cell lines.

Related Keywords

Johns Hopkins University ,Maryland ,United States ,University Of Maryland ,Colorado ,Sybilb Harrington Stein ,Kathleen Jee ,Jaron Sanchez ,Nicole Anders ,Jing Zhang ,Miguel Flores Bellver ,Aumreetam Dinabandhu ,Branna Irving Sisenwein ,Monika Deshpande ,Yousang Hwand ,Chuanyu Guo ,Shaima Salman ,Puchner Applewhite ,Akrit Sodhi ,Maria Valeria Canto Soler ,Gregg Semenza ,Michelle Rudek ,Jiang Qian ,Deepti Sharma ,Silvia Montaner ,Maryland Innovation Initiative ,University Of Colorado ,Johns Hopkins University School Of Medicine ,Johns Hopkins Sidney Kimmel Comprehensive Cancer Center ,Research To Prevent Blindness Inc ,Wilmer Eye Institute ,University Of Colorado School Medicine ,Armstrong Family Foundation ,Cellsight Development Fund ,Ocular Stem Cell Research ,Clinical Investigation ,Irving Sisenwein Professor ,Johns Hopkins University School ,Wilmer Eye ,Brooks Puchner Applewhite ,Colorado School ,Innovation Initiative ,Prevent Blindness ,Special Scholar Award ,Stein Innovations Award ,Doni Solich Family Chair ,Branna Irving Sisenwein Professorship ,